Package Leaflet: Information for the User
Viaflo Hartmann (Lactated Ringer's) Solution for Infusion
Sodium chloride, potassium chloride, calcium chloride dihydrate, and sodium lactate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Keep this leaflet. You may need to read it again.
Contents of the pack and other information:
This medicinal product is referred to as “Solution for Viaflo Hartmann (Lactated Ringer's) solution for infusion”, but will be referred to as “Viaflo Hartmann (Lactated Ringer's)” throughout the rest of this leaflet.
Viaflo Hartmann (Lactated Ringer's) is a solution containing the following substances in water:
Sodium, potassium, calcium, chloride, and lactate are chemical substances (electrolytes) found in the blood.
Viaflo Hartmann (Lactated Ringer's) is used to:
Viaflo Hartmann (Lactated Ringer's) should not be given to you if you have any of the following conditions
Warnings and precautions
Tell your doctor or nurse before you start using Viaflo Hartmann (Lactated Ringer's) if you have or have had any of the following conditions:
Intensive monitoring of your blood potassium levels is required
This may increase the risk of low sodium levels in the blood and can cause headache, nausea, seizures, lethargy, coma, brain swelling, and death. Brain swelling increases the risk of death and brain damage. People at higher risk of brain swelling are:
When you are being given this solution, your doctor may take blood and urine samples to monitor:
Although Viaflo Hartmann (Lactated Ringer's) contains potassium, it does not contain enough to treat very low potassium levels in the blood (severe hypokalemia)
Calcium chloride can be harmful if injected into tissues. Therefore, Viaflo Hartmann (Lactated Ringer's) should not be injected into a muscle (intramuscular injection). Your doctor will also take this into account to avoid the solution penetrating into the tissues around the veins.
Viaflo Hartmann (Lactated Ringer's) should not be administered with the same needle used for a blood transfusion. The red blood cells could be damaged or clumped.
Since Viaflo Hartmann (Lactated Ringer's) contains lactate (a substance present in the body), it can make the blood too alkaline (metabolic alkalosis).
Viaflo Hartmann (Lactated Ringer's) should be administered with special caution to infants under 6 months.
Your doctor should take into account if you are receiving parenteral nutrition (nutrition received through an infusion into a vein). During prolonged treatment with Viaflo Hartmann (Lactated Ringer's), you will need extra nutrition.
Other medicines and Viaflo Hartmann (Lactated Ringer's)
Tell your doctor or nurse if you are taking or have recently taken or might take any other medicines.
It is particularly important that you tell your doctor if you are taking:
These medicines can cause the body to accumulate sodium and water, leading to:
The following medicines can increase the potassium level in the blood. This effect can be life-threatening. It is more likely that you will suffer from high blood potassium levels if you have kidney disease.
(Note that these medicines may be included in some combination medicines)
Some medicines act on the vasopressin hormone. These may include:
Other medicines that may affect or be affected by Viaflo Hartmann (Lactated Ringer's) are:
Using Viaflo Hartmann (Lactated Ringer's) with food and drinks
Ask your doctor about what you can eat or drink.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or think you may be pregnant or are planning to have a baby, ask your doctor or nurse for advice before using this medicine.
Viaflo Hartmann (Lactated Ringer's) can be used safely during pregnancy and breastfeeding.
Your doctor will monitor your blood electrolyte levels and fluid volume.
Calcium can reach the fetus through the placenta and, after birth, through breast milk.
However, if another medicine is added to the infusion solution during pregnancy or breastfeeding, you should:
Driving and using machines
Ask your doctor or pharmacist for advice before driving or using machines.
Viaflo Hartmann (Lactated Ringer's) will be given to you by a doctor or nurse. Your doctor will decide how much you need and when it should be given. This will depend on your age, weight, physical condition, and the reason for treatment. The amount you receive may also be influenced by other treatments you are receiving.
DO NOT receive Viaflo Hartmann (Lactated Ringer's) if there are particles floating in the solution or if the container is damaged in any way.
Viaflo Hartmann (Lactated Ringer's) is usually given to you through a plastic tube connected to a needle inserted into a vein. A vein in the arm is usually used to administer the infusion. However, your doctor may give you the medicine in another way.
Before and during the infusion, your doctor will monitor:
Any unused solution should be discarded. DO NOT receive Viaflo Hartmann (Lactated Ringer's) from a bag that has been partially used.
If you receive more Viaflo Hartmann (Lactated Ringer's) than you should
If you receive too much Viaflo Hartmann (Lactated Ringer's) solution or if it is given too quickly, you may experience the following symptoms:
If you notice any of these symptoms, tell your doctor immediately. The infusion will be stopped, and you will receive treatment based on the symptoms.
If a medicine has been added to Viaflo Hartmann (Lactated Ringer's) before the excessive administration, that medicine may also cause symptoms. You should read the list of possible symptoms in the package leaflet of the added medicine.
Stopping the infusion of Viaflo Hartmann (Lactated Ringer's)
Your doctor will decide when you should stop receiving this infusion.
If you have any further questions on the use of this product, ask your doctor or nurse.
Like all medicines, this medicine may cause adverse effects, although not all people suffer from them.
If you experience any of the following symptoms, inform your doctor or nurse immediately.
The following symptoms may be signs of a severe or even life-threatening hypersensitivity reaction (allergy) called anaphylactic shock:
Higher than normal potassium levels in the blood (hyperkalemia).
Low sodium levels in the blood that can be acquired during hospitalization (nosocomial hyponatremia) and related neurological disorder (acute hyponatremic encephalopathy). Hyponatremia can cause irreversible brain damage and death due to swelling (cerebral edema/inflammation) (see also section 2 "Warnings and Precautions").
Reactions due to the method of administration, manifested by one or more of the following symptoms:
Other adverse effects reported with similar products (other solutions containing sodium lactate) include:
If a medicine has been added to the infusion solution, it can also cause adverse effects. These adverse effects will depend on the added medicine. You should read the list of possible symptoms in the leaflet of the added medicine.
Reporting of Adverse Effects:
If you experience any type of adverse effect, consult your doctor or nurse, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
250 ml bag: Do not store at a temperature above 30°C
500 and 1000 ml bags: no special storage conditions are required.
Viaflo Hartmann (Ringer lactate) should NOT be administered after the expiration date CAD that appears on the bag. The expiration date is the last day of the month indicated.
You should not receive Viaflo Hartmann (Ringer lactate) if there are particles floating in the solution or if the container is damaged in any way.
Composition of Viaflo Hartmann (Ringer lactate)
The active ingredients are:
The only excipient is water for injectable preparations
Appearance of the Product and Package Contents
Viaflo Hartmann (Ringer lactate) is a clear, particle-free solution. It is presented in polyolefin/polyamide (Viaflo) plastic bags. Each bag is packaged in a sealed protective plastic overbag.
The bag sizes are
The bags are packaged in cardboard boxes. Each cardboard box contains one of the following quantities:
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Holder
Baxter S.L.
Pouet de Camilo 2, 46394 Ribarroja del Turia (Valencia) Spain
Manufacturer:
Bieffe Medital S.A.
Ctra de Biescas, Senegüé
22666 Sabiñanigo (Huesca)
Spain
Baxter SA
Boulevard René Branquart, 80
7860 Lessines
Belgium
Date of the Last Revision of this Leaflet: November 2018
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
-------------------------------------------------------------------------------------------------------------------
This information is intended only for healthcare professionals
Handling and Preparation
Parenteral solutions should be visually inspected for particles and discoloration before administration, when the solution and container allow it. Do not administer unless the solution is clear and the container is intact.
Do not remove the bag from its overbag until it is ready for use. The inner bag maintains the sterility of the product. Administer immediately after connecting the infusion equipment.
Do not connect plastic containers in series. This type of use can produce gas embolisms due to residual air drawn from the primary container before the liquid contained in the secondary container is completely administered. The pressurization of intravenous solutions in flexible plastic containers to increase flow rates can lead to a gas embolism if the residual air in the container is not fully evacuated before administration. The use of an intravenous administration set with a ventilation filter in the open position could cause a gas embolism. This type of intravenous administration set with a ventilation filter in the open position should not be used with flexible plastic containers.
The solution is for intravenous administration with a sterile administration set using an aseptic technique. The set must be primed with the solution to prevent air from entering the system.
Added medications can be introduced before or during infusion through the injection point.
When medications are added, the isotonicity should be checked before parenteral administration. It is essential that the mixing of products is done under extreme asepsis conditions. Solutions containing added medications should be used immediately and not stored.
The addition of other medications or the use of an incorrect administration technique can cause the appearance of febrile reactions due to the possible introduction of pyrogens. In case of an adverse reaction, the infusion should be interrupted immediately.
Discard after a single use.
Discard partially used bags.
Do not reconnect partially used bags.
Use sterile material for preparation and administration.
Warning: Added medications may be incompatible. Check the compatibility of the added medication with the solution and container before use. When medications are added, the isotonicity should be checked before parenteral administration (see section 5 "Incompatibilities of Added Medications").
To Add Medication Before Administration
Caution: do not store bags with added medication.
To Add Medication During Administration
Before use, the physical and chemical stability of any added medication should be established at the pH of the Viaflo Hartmann (Ringer lactate) solution in the Viaflo container.
From a microbiological point of view, the diluted product should be used immediately unless the addition of medications has been carried out under controlled and validated aseptic conditions. If it is not used immediately, the conditions and storage times used before use are the responsibility of the user
Ceftriaxone should not be mixed with solutions that contain calcium, including Viaflo Hartmann (Ringer lactate)
As with all parenteral solutions, added medications may be incompatible; therefore, the compatibility of added medications with Viaflo Hartmann (Ringer lactate) should be verified before addition.
After adding a medication, the incompatibility of the added medication with Viaflo Hartmann (Ringer lactate) should be visible by a change in color and/or precipitate, insoluble complexes, or appearance of crystals. The leaflet of the medication to be added or any other relevant source should be consulted.
Before adding a medication, verify that it is soluble and/or stable in water at the pH range of Viaflo Hartmann (Ringer lactate) (pH 5.0 - 7.0).
When medications are added to Viaflo Hartmann (Ringer lactate), an aseptic technique should be used. Mix the solution well when added medications have been introduced. Do not store solutions with added medications.
The following list of incompatible medications with Viaflo Hartmann (Ringer lactate) serves as a guide (non-exhaustive list):
concentration of 2%-3% stable for 4 hours
concentration >3% should be administered within 1 hour
Medications that are known to be incompatible should not be used.